Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain

Published:2000-12 Issue:18 Volume:36 Page:2344-2352
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

González-Larriba J.L,Serrano S,Alvarez-Mon M,Camacho F,Casado M.A,Dı́az-Pérez J.L,Dı́az-Rubio E,Fosbrook L,Guillem V,López-López J.J,Moreno-Nogueira J.A,Toribio J

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. The European School of Oncology. http://www.oncoweb.com/start/

2. Cancer statistics, 1997;Parker;CA Cancer J. Clin.,1997

3. Alvarez-Mon M, Camacho F, Dı́az-Pérez JL, et al. Epidemiologı́a. In: Panorámica Actual del Melanoma. Madrid, Acción Médica, 1997, 17–24.

4. Malignant melanoma;Morton,1996

5. Finally, a successful adjuvant therapy for high-risk melanoma;Balch;J. Clin. Oncol.,1996

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States;Advances in Therapy;2023-05-16

2. Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland;Journal of Medical Economics;2023-02-15

3. Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States;Journal of Medical Economics;2019-05-17

4. Cost-Effectiveness of Drug Treatments for Advanced Melanoma: A Systematic Literature Review;PharmacoEconomics;2017-05-27

5. Cost–effectiveness of therapies for melanoma;Expert Review of Pharmacoeconomics & Outcomes Research;2015-02-23